HD Labs Tirzepatide 30 mg –1 Vial (Not Mixed)

Tirzepatide

Tirzepatide is a prescription medication used alongside diet and physical activity to help improve blood-sugar control in eligible patients with type 2 diabetes. Depending on the registered product and local approval, tirzepatide may also be prescribed for long-term weight management in qualifying patients.

Tirzepatide acts on two naturally occurring hormone pathways: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Activating these receptors can support glucose-dependent insulin release, reduce inappropriate glucagon secretion, slow gastric emptying and promote a feeling of fullness.

Clinical studies have shown that tirzepatide can improve measures of blood-sugar control and may support meaningful weight reduction when used as part of an appropriate, medically supervised treatment programme.

Tirzepatide should only be used under the direction of a qualified healthcare professional. The appropriate product, dose and treatment schedule must be determined individually. Patients should review the approved prescribing information, contraindications, warnings and possible side effects before treatment.

Prescription medicine: Product indications, packaging and approved uses may differ by country and brand. This information is intended for general product guidance and does not replace professional medical advice.